Brief: Iteos Therapeutics Q2 Earnings Per Share $0.15
Iteos Therapeutics Inc ITOS.O :
* CASH BALANCE IS EXPECTED TO PROVIDE COMPANY RUNWAY INTO
2026
* Q2 EARNINGS PER SHARE $0.15
* Q2 EARNINGS PER SHARE VIEW $1.20 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNE1Ts13t
Further company coverage: ITOS.O
Recent news on iTeos Therapeutics
See all newsIteos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Iteos Therapeutics Inc expected to post a loss of $1.01 a share - Earnings Preview
Brief: Iteos Therapeutics Enters Into Agreement To Be Acquired By Concentra Biosciences For $10.047 In Cash Per Share Plus A Contingent Value Right
U.S. STOCKS ON THE MOVE-Nvidia, Salesforce, Kestrel Group
U.S. STOCKS ON THE MOVE-Dick's Sporting Goods, Sonic Automotive